持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/26 | 3,120 | 3,145 | 3,100 | 3,130 | +30 | +1% | 32,400 |
| 2024/06/25 | 3,085 | 3,115 | 3,060 | 3,100 | +15 | +0.5% | 43,000 |
| 2024/06/24 | 3,075 | 3,115 | 3,070 | 3,085 | +15 | +0.5% | 34,500 |
| 2024/06/21 | 3,040 | 3,085 | 3,025 | 3,070 | +40 | +1.3% | 63,000 |
| 2024/06/20 | 3,015 | 3,040 | 3,010 | 3,030 | +15 | +0.5% | 24,700 |
| 2024/06/19 | 2,989 | 3,015 | 2,988 | 3,015 | +25 | +0.8% | 19,500 |
| 2024/06/18 | 2,987 | 3,005 | 2,979 | 2,990 | +18 | +0.6% | 30,300 |
| 2024/06/17 | 2,903 | 2,972 | 2,901 | 2,972 | +50 | +1.7% | 35,500 |
| 2024/06/14 | 2,863 | 2,935 | 2,863 | 2,922 | +52 | +1.8% | 60,800 |
| 2024/06/13 | 2,963 | 2,963 | 2,870 | 2,870 | -113 | -3.8% | 83,700 |
| 2024/06/12 | 3,025 | 3,040 | 2,973 | 2,983 | -97 | -3.1% | 56,300 |
| 2024/06/11 | 3,115 | 3,120 | 3,080 | 3,080 | -30 | -1% | 20,500 |
| 2024/06/10 | 3,050 | 3,115 | 3,050 | 3,110 | +60 | +2% | 19,800 |
| 2024/06/07 | 3,035 | 3,060 | 3,030 | 3,050 | +5 | +0.2% | 16,000 |
| 2024/06/06 | 3,075 | 3,090 | 3,035 | 3,045 | -30 | -1% | 18,700 |
| 2024/06/05 | 3,065 | 3,085 | 3,045 | 3,075 | +15 | +0.5% | 35,100 |
| 2024/06/04 | 3,030 | 3,090 | 3,030 | 3,060 | +25 | +0.8% | 35,700 |
| 2024/06/03 | 3,030 | 3,060 | 3,025 | 3,035 | +5 | +0.2% | 30,800 |
| 2024/05/31 | 2,975 | 3,035 | 2,961 | 3,030 | +79 | +2.7% | 71,300 |
| 2024/05/30 | 2,921 | 2,965 | 2,902 | 2,951 | +26 | +0.9% | 29,500 |
| 2024/05/29 | 2,928 | 2,945 | 2,924 | 2,925 | -3 | -0.1% | 27,000 |
| 2024/05/28 | 2,950 | 2,957 | 2,928 | 2,928 | -30 | -1% | 26,500 |
| 2024/05/27 | 2,966 | 2,966 | 2,930 | 2,958 | +3 | +0.1% | 35,000 |
| 2024/05/24 | 2,945 | 2,966 | 2,931 | 2,955 | -2 | -0.1% | 30,900 |
| 2024/05/23 | 2,989 | 2,989 | 2,941 | 2,957 | -38 | -1.3% | 35,100 |
| 2024/05/22 | 3,030 | 3,030 | 2,991 | 2,995 | -10 | -0.3% | 44,000 |
| 2024/05/21 | 3,040 | 3,060 | 3,005 | 3,005 | -40 | -1.3% | 36,700 |
| 2024/05/20 | 3,030 | 3,060 | 3,030 | 3,045 | -10 | -0.3% | 35,400 |
| 2024/05/17 | 3,055 | 3,055 | 3,030 | 3,055 | ±0 | ±0% | 13,900 |
| 2024/05/16 | 3,060 | 3,065 | 3,025 | 3,055 | ±0 | ±0% | 28,900 |
| 2024/05/15 | 3,120 | 3,120 | 3,055 | 3,055 | -65 | -2.1% | 30,600 |
| 2024/05/14 | 3,155 | 3,170 | 3,100 | 3,120 | -30 | -1% | 39,600 |
| 2024/05/13 | 3,210 | 3,245 | 3,130 | 3,150 | -80 | -2.5% | 26,800 |
| 2024/05/10 | 3,225 | 3,230 | 3,195 | 3,230 | +15 | +0.5% | 20,700 |
| 2024/05/09 | 3,190 | 3,230 | 3,185 | 3,215 | +25 | +0.8% | 19,400 |
| 2024/05/08 | 3,205 | 3,210 | 3,180 | 3,190 | -15 | -0.5% | 28,500 |
| 2024/05/07 | 3,215 | 3,215 | 3,170 | 3,205 | +15 | +0.5% | 20,500 |
| 2024/05/02 | 3,195 | 3,210 | 3,175 | 3,190 | -15 | -0.5% | 13,200 |
| 2024/05/01 | 3,160 | 3,210 | 3,160 | 3,205 | +15 | +0.5% | 18,600 |
| 2024/04/30 | 3,155 | 3,190 | 3,145 | 3,190 | +45 | +1.4% | 40,900 |
| 2024/04/26 | 3,145 | 3,145 | 3,090 | 3,145 | +30 | +1% | 90,700 |
| 2024/04/25 | 3,145 | 3,145 | 3,110 | 3,115 | -40 | -1.3% | 25,000 |
| 2024/04/24 | 3,160 | 3,165 | 3,145 | 3,155 | -10 | -0.3% | 20,200 |
| 2024/04/23 | 3,150 | 3,165 | 3,135 | 3,165 | +15 | +0.5% | 20,400 |
| 2024/04/22 | 3,120 | 3,160 | 3,120 | 3,150 | +60 | +1.9% | 16,500 |
| 2024/04/19 | 3,105 | 3,120 | 3,060 | 3,090 | -25 | -0.8% | 33,300 |
| 2024/04/18 | 3,115 | 3,130 | 3,105 | 3,115 | +10 | +0.3% | 12,700 |
| 2024/04/17 | 3,125 | 3,140 | 3,105 | 3,105 | -40 | -1.3% | 30,000 |
| 2024/04/16 | 3,115 | 3,145 | 3,115 | 3,145 | -20 | -0.6% | 27,200 |
| 2024/04/15 | 3,125 | 3,165 | 3,115 | 3,165 | ±0 | ±0% | 26,700 |
101～
150
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 332,000円 | +3.0% | +27.5% | 2.41% | 21.02倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 285,000円 | +52.1% | +23.3% | 0.00% | 20.23倍 | 3.88倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 466,500円 | +12.0% | +28.1% | 2.57% | 25.71倍 | 1.09倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 222,100円 | +13.6% | +29.2% | 2.07% | 11.52倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,700円 | +197.7% | - | 0.00% | 46.47倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
